CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
CNBX Pharmaceuticals Debt to Equity Ratio : -0.4388 for May 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.4388 |
| February 28, 2026 | -0.46 |
| November 30, 2025 | -0.4845 |
| August 31, 2025 | -0.4796 |
| May 31, 2025 | -0.5281 |
| February 28, 2025 | -0.5442 |
| November 30, 2024 | -0.5283 |
| August 31, 2024 | -0.5222 |
| May 31, 2024 | -0.5271 |
| February 29, 2024 | -0.5481 |
| November 30, 2023 | -0.6273 |
| August 31, 2023 | -0.666 |
| May 31, 2023 | -0.6979 |
| February 28, 2023 | -0.7653 |
| November 30, 2022 | -0.8931 |
| August 31, 2022 | -1.077 |
| May 31, 2022 | -1.357 |
| February 28, 2022 | -2.045 |
| November 30, 2021 | 1.703 |
| August 31, 2021 | 0.4828 |
| May 31, 2021 | 0.4516 |
| February 28, 2021 | 0.2029 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.00 |
| November 30, 2019 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | -0.0362 |
| November 30, 2015 | 0.1271 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | -0.8016 |
| November 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
| Definium Therapeutics, Inc. | 0.0397 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0128M |
| Total Liabilities (Quarterly) | 2.672M |
| Shareholders Equity (Quarterly) | -2.660M |
| Current Ratio | 0.0048 |
| Net Debt Paydown Yield | 15.69% |